Abstract:BACKGROUND:CD4(+)CD25(+) regulatory T cell (Treg)-based immunotherapy is considered a promising regimen for controlling the progression of autoimmune diabetes. In this study, we tested the hypothesis that the therapeutic effects of Tregs in response to the antigenic epitope stimulation depend on the structural properties of the epitopes used. METHODOLOGY/PRINCIPAL FINDINGS:Splenic lymphocytes from nonobese diabetic (NOD) mice were stimulated with different glutamic acid decarboxylase (GAD)-derived epitopes for 7-10 days and the frequency and function of Tregs was analyzed. We found that, although all expanded Tregs showed suppressive functions in vitro, only p524 (GAD524-538)-expanded CD4(+)CD25(+) T cells inhibited diabetes development in the co-transfer models, while p509 (GAD509-528)- or p530 (GAD530-543)-expanded CD4(+)CD25(+) T cells had no such effects. Using computer-guided molecular modeling and docking methods, the differences in structural characteristics of these epitopes and the interaction mode (including binding energy and identified domains in the epitopes) between the above-mentioned epitopes and MHC class II I-A(g7) were analyzed. The theoretical results showed that the epitope p524, which induced protective Tregs, possessed negative surface-electrostatic potential and bound two chains of MHC class II I-A(g7), while the epitopes p509 and p530 which had no such ability exhibited positive surface-electrostatic potential and bound one chain of I-A(g7). Furthermore, p524 bound to I-A(g7) more stably than p509 and p530. Of importance, we hypothesized and subsequently confirmed experimentally that the epitope (GAD570-585, p570), which displayed similar characteristics to p524, was a protective epitope by showing that p570-expanded CD4(+)CD25(+) T cells suppressed the onset of diabetes in NOD mice. CONCLUSIONS/SIGNIFICANCE:These data suggest that molecular modeling-based structural analysis of epitopes may be an instrumental tool for prediction of protective epitopes to expand functional Tregs.

Effect of Displaying P277 Peptide on Surface of L-asparaginase on Its Antigenicity and Efficacy of Autoimmune Diabetes Prevention in NOD Mice

Expression and Purification of Peptide P277 and Its Primary Pharmacology

Direct Transfer of A20 Gene into Pancreas Protected Mice from Streptozotocin-Induced Diabetes

Vaccination of non-obese diabetic mice with a fragment of peptide P277 attenuates insulin-dependent diabetes mellitus

Active Tolerance Induction and Prevention of Autoimmune Diabetes by Immunogene Therapy Using Recombinant Adenoassociated Virus Expressing Glutamic Acid Decarboxylase 65 Peptide Gad(500-585)

Oral Delivery of Single-Chain Insulin (SCI-59) Analog by Bacterium-Like Particles (blps) Induces Oral Tolerance and Prevents Autoimmune Diabetes in NOD Mice.

Intranasal Vaccination with P277 Tandem Repeat Sequences Carried by Hsp65 Prevented Type 1 Diabetes in NOD Mice

[Improved Efficacy of P277 Fused to Heat Shock Protein 65 of Mycobacterium Tuberculosis Against Diabetes in Nonobese Diabetic Mice].

Enhanced Immunogenicity of Peptide P277 by Heat Shock Protein Hsp65 Vector Carrying Tandem Repeats of P277 to Prevent Type 1 Diabetes in Nod Mice

Asparaginase Display of Human Cholesteryl Ester Transfer Protein (cetp)b Cell Epitopes for Inducing High Titers of Anti-Cetp Antibodies in Vivo

Asparaginase Display of Polypeptides in the Periplasm of Escherichia Coli: Potential Rapid Pepscan Technique for Antigen Epitope Mapping.

Glutamic Acid Decarboxylase-Derived Epitopes with Specific Domains Expand CD4(+)CD25(+) Regulatory T Cells.

Study on the Possibility of Foreign Peptide Display on the Surface of Escherichia Coli L-Asparaginase Ⅱ

A Th1-recognized peptide P277, when tandemly repeated, enhances a Th2 immune response toward effective vaccines against autoimmune diabetes in nonobese diabetic mice.

Oral Administration of Recombinant Lactococcus Lactis Expressing Hsp65 and Tandemly Repeated P277 Reduces the Incidence of Type I Diabetes in Non-Obese Diabetic Mice

Role of GAD peptides p217 and p290 in the repair of INS receptor in salivary tissues of type 1 diabetic mice

Immunotherapy of Autoimmune Diabetes by Nasal Administration of Tandem Glutamic Acid Decarboxylase 65 Peptides

HSP65 serves as an immunogenic carrier for a diabetogenic peptide P277 inducing anti-inflammatory immune response in NOD mice by nasal administration.

Oral Delivery of Staphylococcal Nuclease by Lactococcus Lactis Prevents Type 1 Diabetes Mellitus in NOD Mice

Oral Administration of Lactococcus Lactis-Expressing Heat Shock Protein 65 and Tandemly Repeated IA2P2 Prevents Type 1 Diabetes in NOD Mice.

Study on the Hypoglycemic Mechanism of the Fusion Protein HSP65-6×P277 in NOD Mice